WHO ICTRP trial
Etude de phase I / II de l’association carboplatine et topotecan oral…
EUCTR2008-001842-19-FR · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2008-001842-19-FR |
|---|---|
| Public title | Etude de phase I / II de l’association carboplatine et topotecan oral hebdomadaire chez des patientes atteintes de cancer du col de l’utérus métastatique ou en rechute. - HYCAR |
| Scientific title | Etude de phase I / II de l’association carboplatine et topotecan oral hebdomadaire chez des patientes atteintes de cancer du col de l’utérus métastatique ou en rechute. - HYCAR |
| Primary sponsor | ARCAGY |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Countries | France |
| Conditions | ASSOCIATION CARBOPLATINE ET TOPOTECAN ORAL HEBDOMADAIRE CHEZ DES PATIENTES ATTEINTES DE CANCER DU COL DE L’UTERUS METASTATIQUE OU EN RECHUTE MedDRA version: 9.1 Level: LLT Classification code 10064444 Term: Invasive cervix cancer |
| Interventions | Trade Name: HYCAMTIN Product Name: topotecan Pharmaceutical Form: Capsule* INN or Proposed INN: TOPOTECAN HYDROCHLORIDE CAS Number: 119413546 Concentration unit: mg/m2 milligram(s)/square meter Concentration type: equal Concentration… |
| Registration date | Jul 7, 2008 |
| Secondary IDs | GINECO-CE103 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: